Exicure (XCUR) Other Non-Current Assets (2016 - 2026)

Exicure (XCUR) reported Other Non-Current Assets of $821000.0 for Q1 2026, down 43.34% on a YoY basis from $1.4 million in Q1 2025, and down 11.53% quarter-over-quarter from $928000.0 in Q4 2025.

Exicure (XCUR) Other Non-Current Assets (2016 - 2026) Analysis & Trends

Exicure has reported Other Non-Current Assets for 11 years, with the latest figure at $821000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 43.34% year-over-year to $821000.0; the trailing twelve-month figure through Mar 2026 stood at $821000.0 (down 43.34% YoY), and the FY2025 full-year result was $928000.0, down 31.61% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $821000.0, down from $928000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $3.5 million in Q4 2022, with the low at $821000.0 in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $2.0 million across 5 years, with a median of $1.9 million in 2025.
  • The largest YoY upside for Other Non-Current Assets was 150.57% in 2023 against a maximum downside of 65.62% in 2023.
  • Exicure's Other Non-Current Assets stood at $3.5 million in 2022, then tumbled by 65.62% to $1.2 million in 2023, then advanced by 13.08% to $1.4 million in 2024, then plunged by 31.61% to $928000.0 in 2025, then retreated by 11.53% to $821000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $821000.0 (Q1 2026), $928000.0 (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 60,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1.26 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Exicure 19.38 Mn 16.77 Mn - 821,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 821,000.00
Dec 31, 2025 928,000.00
Sep 30, 2025 1.89 Mn
Jun 30, 2025 1.99 Mn
Mar 31, 2025 1.45 Mn
Dec 31, 2024 1.36 Mn
Sep 30, 2024 2.07 Mn
Jun 30, 2024 2.44 Mn
Mar 31, 2024 2.88 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 3.09 Mn
Jun 30, 2023 3.20 Mn
Mar 31, 2023 3.31 Mn
Dec 31, 2022 3.49 Mn
Sep 30, 2022 1.28 Mn
Jun 30, 2022 1.30 Mn
Mar 31, 2022 1.32 Mn
Dec 31, 2021 9.33 Mn
Sep 30, 2021 1.47 Mn
Jun 30, 2021 1.44 Mn